Format

Send to:

Choose Destination
See comment in PubMed Commons below
Reprod Toxicol. 2008 Sep;26(1):24-30. doi: 10.1016/j.reprotox.2008.05.065. Epub 2008 Jun 7.

The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.

Author information

  • 1Pharmakovigilanz- und Beratungszentrum für Embryonaltoxikologie, (BBGes), Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Spandauer Damm 130, Haus 10, 14050 Berlin, Germany. weber@embryotox.de

Abstract

OBJECTIVE:

To assess the safety of calcium channel blockers during the first trimester of pregnancy.

STUDY DESIGN:

A multicenter (n=11), prospective observational study of the European Network of Teratology Information Services (ENTIS). The rate of major birth defects was compared between a cohort of pregnant women exposed to calcium channel blockers during the first trimester (n=299) and a control group not exposed to potential teratogens (n=806).

RESULTS:

Major birth defects were not more common in the study group than in the control group. Birth weight was significantly lower in exposed term newborns. There were more preterm infants in the study group than in the control group (23.8% vs. 6.5%). These adverse effects are more likely due to the underlying disease than to the medication.

CONCLUSION:

This study suggests that calcium channel blockers during the first trimester of pregnancy do not represent a major teratogenic risk.

PMID:
18585452
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk